Canada · Delayed Price · Currency is CAD CareRx Statistics
Total Valuation
CareRx has a market cap or net worth of CAD 205.57 million. The enterprise value is 268.86 million.
| Market Cap | 205.57M |
| Enterprise Value | 268.86M |
Important Dates
The next estimated earnings date is Friday, August 7, 2026.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | Jun 23, 2026 |
Share Statistics
CareRx has 63.45 million shares outstanding. The number of shares has increased by 5.95% in one year.
| Current Share Class | 63.45M |
| Shares Outstanding | 63.45M |
| Shares Change (YoY) | +5.95% |
| Shares Change (QoQ) | +0.85% |
| Owned by Insiders (%) | 1.51% |
| Owned by Institutions (%) | 27.42% |
| Float | 34.17M |
Valuation Ratios
The trailing PE ratio is 7.61 and the forward PE ratio is 17.12.
| PE Ratio | 7.61 |
| Forward PE | 17.12 |
| PS Ratio | 0.55 |
| PB Ratio | 1.86 |
| P/TBV Ratio | 23.05 |
| P/FCF Ratio | 8.29 |
| P/OCF Ratio | 6.77 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.20, with an EV/FCF ratio of 10.84.
| EV / Earnings | 9.93 |
| EV / Sales | 0.72 |
| EV / EBITDA | 9.20 |
| EV / EBIT | 21.84 |
| EV / FCF | 10.84 |
Financial Position
The company has a current ratio of 1.10, with a Debt / Equity ratio of 0.71.
| Current Ratio | 1.10 |
| Quick Ratio | 0.75 |
| Debt / Equity | 0.71 |
| Debt / EBITDA | 2.67 |
| Debt / FCF | 3.15 |
| Interest Coverage | 1.91 |
Financial Efficiency
Return on equity (ROE) is 27.51% and return on invested capital (ROIC) is 7.09%.
| Return on Equity (ROE) | 27.51% |
| Return on Assets (ROA) | 3.26% |
| Return on Invested Capital (ROIC) | 7.09% |
| Return on Capital Employed (ROCE) | 6.66% |
| Weighted Average Cost of Capital (WACC) | 7.35% |
| Revenue Per Employee | 252,606 |
| Profits Per Employee | 18,253 |
| Employee Count | 1,533 |
| Asset Turnover | 1.59 |
| Inventory Turnover | 13.91 |
Taxes
| Income Tax | -22.21M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +9.46% in the last 52 weeks. The beta is 0.62, so CareRx's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | +9.46% |
| 50-Day Moving Average | 3.50 |
| 200-Day Moving Average | 3.61 |
| Relative Strength Index (RSI) | 42.62 |
| Average Volume (20 Days) | 51,772 |
Short Selling Information
The latest short interest is 865, so 0.00% of the outstanding shares have been sold short.
| Short Interest | 865 |
| Short Previous Month | 1,548 |
| Short % of Shares Out | 0.00% |
| Short % of Float | 0.00% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CareRx had revenue of CAD 374.61 million and earned 27.07 million in profits. Earnings per share was 0.43.
| Revenue | 374.61M |
| Gross Profit | 112.74M |
| Operating Income | 12.31M |
| Pretax Income | 4.86M |
| Net Income | 27.07M |
| EBITDA | 25.19M |
| EBIT | 12.31M |
| Earnings Per Share (EPS) | 0.43 |
Balance Sheet
The company has 14.84 million in cash and 78.13 million in debt, with a net cash position of -63.29 million or -1.00 per share.
| Cash & Cash Equivalents | 14.84M |
| Total Debt | 78.13M |
| Net Cash | -63.29M |
| Net Cash Per Share | -1.00 |
| Equity (Book Value) | 110.39M |
| Book Value Per Share | 1.75 |
| Working Capital | 6.46M |
Cash Flow
In the last 12 months, operating cash flow was 30.37 million and capital expenditures -5.55 million, giving a free cash flow of 24.81 million.
| Operating Cash Flow | 30.37M |
| Capital Expenditures | -5.55M |
| Depreciation & Amortization | 12.88M |
| Net Borrowing | -10.74M |
| Free Cash Flow | 24.81M |
| FCF Per Share | 0.39 |
Margins
Gross margin is 30.09%, with operating and profit margins of 3.29% and 7.23%.
| Gross Margin | 30.09% |
| Operating Margin | 3.29% |
| Pretax Margin | 1.30% |
| Profit Margin | 7.23% |
| EBITDA Margin | 6.73% |
| EBIT Margin | 3.29% |
| FCF Margin | 6.62% |
Dividends & Yields
This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 2.47%.
| Dividend Per Share | 0.08 |
| Dividend Yield | 2.47% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 9.30% |
| Buyback Yield | -5.95% |
| Shareholder Yield | -3.48% |
| Earnings Yield | 13.17% |
| FCF Yield | 12.07% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for CareRx is 5.14, which is 58.64% higher than the current price. The consensus rating is "Buy".
| Price Target | 5.14 |
| Price Target Difference | 58.64% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 3.84% |
| EPS Growth Forecast (3Y) | 93.98% |
Stock Splits
The last stock split was on June 25, 2020. It was a reverse split with a ratio of 0.05.
| Last Split Date | Jun 25, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
CareRx has an Altman Z-Score of 1.12 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.12 |
| Piotroski F-Score | 7 |